NORDIC BIOSITE ApS
CVR 30711572 · Private limited company (ApS) · Active · Low risk
NORDIC BIOSITE ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry aktiviteter inden for hospitalsvæsen. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 19 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 1.8m and a net result of DKK 1.2m. CEO: Rasmus Valdemar Lind.
Bankruptcy risk for NORDIC BIOSITE ApS
0.0 × the average (1.41%) · higher risk than 18% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 30711572
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (19 years)
- Address
- c/o SVERIGES HANDELSKONTOR, Landgreven 3, st. th
1301 København K - Municipality
- København
- Industry
- Aktiviteter inden for hospitalsvæsen (861000)
Bankruptcies in the industry: Praktiserende tandlæger - Share capital
- DKK 125k
- Employees
- 2 (2018)
- Auditor
- KPMG P/S
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 19 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 48.1% |
| Current ratio | 193% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 12 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 37 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 6.6m | DKK 6.6m |
| Net profit | DKK 1.2m | DKK 1.2m |
| Equity | DKK 1.8m | DKK 2.1m |
| Total assets | DKK 3.8m | DKK 4.2m |
| Short-term debt | DKK 2.0m | – |
| Avg. employees | 3 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · KPMG P/SStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 141 | ||
| 1 Jan 2024 – 31 Dec 2024 | 99 | ||
| 1 Jan 2023 – 31 Dec 2023 | 115 | ||
| 1 Jan 2022 – 31 Dec 2022 | 115 | ||
| 1 Jan 2021 – 31 Dec 2021 | 97 | ||
| 1 Jan 2020 – 31 Dec 2020 | 109 | ||
| 1 Jan 2019 – 31 Dec 2019 | 71 | ||
| 1 Jan 2018 – 31 Dec 2018 | 87 | ||
| 1 Jan 2017 – 31 Dec 2017 | 113 | ||
| 1 Jan 2016 – 31 Dec 2016 | 117 | ||
| 1 Jan 2015 – 31 Dec 2015 | 123 | ||
| 1 Jan 2014 – 31 Dec 2014 | 71 | ||
| 1 Jan 2013 – 31 Dec 2013 | 101 | ||
| 1 Jan 2012 – 31 Dec 2012 | 103 | ||
| 1 Jan 2011 – 31 Dec 2011 | 87 | ||
| 1 Jan 2010 – 31 Dec 2010 | 130 | ||
| 1 Jan 2009 – 31 Dec 2009 | 180 | ||
| 1 Jan 2008 – 31 Dec 2008 | 182 | ||
| 22 Jun 2007 – 31 Dec 2007 | 91 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Rasmus Valdemar Lind | Current | |
| CEO | Yvonne Diana Zar | ||
| CEO | Lars Olof Erhard Gisterå | ||
| CEO | Camilla Eva Duborn | ||
| CEO | Sune Schmølker | ||
| CEO | Sara Sadi Varnam Khasti | ||
| CEO | John Philip Bergquist | ||
| Board | Rasmus Valdemar Lind | Current | |
| Board | Claudia Maria Carolina Berron Osorno | Current | |
| Board | Carl Mikael Zar | ||
| Board | Per-Axel Goran Axelsson | ||
| Board | Yvonne Diana Zar | ||
| Board | Lars Gunnar Björk | ||
| Board | Lars Peter Bräutigam | ||
| Board | Eva Veronica Zar Öhrn | ||
| Board | Magnus Åke Lundberg | ||
| Board | Wilhelmus Catharina Martinus van Hamond | ||
| Board | Lars Olof Erhard Gisterå | ||
| Board | Sune Schmølker | ||
| Board | Lars Olof Erhard Gisterå | ||
| Board | John Philip Bergquist | ||
| Owner (100%) | Nordic Biosite AB | Current | |
| Auditor | KPMG P/S | Current | |
| Auditor | EY Danmark A/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Nordic Biosite AB | Current |
The CEOs' other companies
Sune Schmølker – 3 other companies
- BioTwin ApS Active
- SCANEX MEDICAL SYSTEMS A/S Active
- Scanex Medical Nordics ApS Active
Address history (1 moves)
| c/o SVERIGES HANDELSKONTOR, Landgreven 3, st. th, 1301 København K | |
| c/o SVERIGES HANDELSKONTOR, Toldbodgade 18, 5., 1253 København K |
Employees per year
Other companies at the same address
- FUNDRAIZERS ApS Bankrupt
- MARKET CONSULTANCY A/S Bankrupt
- Pladsmændene Øresund ApS Bankrupt
- Rapide Denmark ApS Bankrupt
- SELSKABET AF 20. JUNI 2000 A/S Bankrupt
- UNLIMIT ApS Bankrupt
- ZPIN ApS Bankrupt
- Advania Danmark A/S Fusioneret
- CAFÉ COBRA ApS Compulsorily dissolved
- CGP HOLDING ApS Opløst
- Calabrio Denmark ApS Active
- E9 Solutions ApS Active
- EMU Growth Partners Denmark ApS Active
- FOOTWAY ApS Opløst
- FORSIKRINGSMÆGLERGRUPPEN PENSION ApS (FMG PENSION) Fusioneret
- Gazechim Composites Danmark ApS Active
- GoodMonday ApS Opløst
- GreenMobility A/S Active
- GreenMobility København A/S Opløst
- Hygglo ApS Active
- Høvding-Holding ApS Opløst
- J. LINDEBERG DANMARK ApS Active
- LEIJMA ApS Opløst
- Menskopp Danmark ApS Opløst
- Ondio ApS Active
Similar companies in København
- Egeland Healthcare ApS København Ø
- Hårdoktor ApS København K
- In Flow Institute ApS. København N
- Nova Psykiatri ApS København S
- Hyperhidrose klinikken ApS København NV
- Lægens Vaccinationsklinik ApS København S
- Arthroplasty Services Denmark ApS København Ø
- Blue Crown ApS København Ø
- Activemotion Klinik & Hospital ApS Hellerup
- Kæbekirurgisk Klinik ApS København K
- COPENHAGEN NORTH ApS København S
- Scanningsklinikken Ballerup ApS København Ø
Questions and answers about NORDIC BIOSITE ApS
Has NORDIC BIOSITE ApS gone bankrupt?
No, NORDIC BIOSITE ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of NORDIC BIOSITE ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of NORDIC BIOSITE ApS?
Rasmus Valdemar Lind is the CEO of NORDIC BIOSITE ApS.
Who is the auditor of NORDIC BIOSITE ApS?
NORDIC BIOSITE ApS most recently used KPMG P/S.
When was NORDIC BIOSITE ApS founded?
NORDIC BIOSITE ApS was founded on 22 June 2007.
What is the equity of NORDIC BIOSITE ApS?
Equity was DKK 1.8m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.